Volume 90 Issue 38 | p. 17 | Concentrates
Issue Date: September 17, 2012

Cambridge Major Expands Capacity

Department: Business
Keywords: contract manufacturing, pharmaceuticals, fine chemicals

Cambridge Major Laboratories has expanded its large-scale active pharmaceutical ingredient facility in Germantown, Wis. The custom manufacturer is among a group of firms that has been investing in U.S. assets, particularly in the Midwest. “Our faith in the ‘invest in the West’ policy initiated a few years ago continues to bear fruit,” CEO Brian Scanlan says. The company says it added reactor capacity and isolation equipment to support increasing demand for commercial and late-stage development products. It plans to add product-containment capabilities at its Weert, the Netherlands, facility later this year.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment